These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27998471)

  • 1. [Economic burden of cancer in China during 1996-2014: a systematic review].
    Shi JF; Shi CL; Yue XP; Huang HY; Wang L; Li J; Lou PA; Mao AY; Dai M
    Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):929-941. PubMed ID: 27998471
    [No Abstract]   [Full Text] [Related]  

  • 2. [Economic burden of esophageal cancer in China from 1996 to 2015: a systematic review].
    Guo LW; Shi CL; Huang HY; Wang L; Yue XP; Liu SZ; Li J; Su K; Dai M; Sun XB; Shi JF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):102-109. PubMed ID: 28100387
    [No Abstract]   [Full Text] [Related]  

  • 3. [Economic burden of stomach cancer in China during 1996-2015: a systematic review].
    Yao F; Shi CL; Liu CC; Wang L; Song SM; Ren JS; Guo CG; Lou PA; Dai M; Zhu L; Shi JF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Aug; 51(8):756-762. PubMed ID: 28763928
    [No Abstract]   [Full Text] [Related]  

  • 4. [Priority setting in scaled-up cancer screening in China: an systematic review of economic evaluation evidences].
    Shi JF; Mao AY; Bai YN; Liu GX; Liu CC; Wang H; Cao MM; Feng H; Wang L; Bai FZ; Huang HY; Bai HJ; Zhu J; Yan XX; Zhang J; Ren JS; Li N; Dai M; Chen WQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Mar; 54(3):306-313. PubMed ID: 32187937
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002-2011).
    Guo LW; Huang HY; Shi JF; Lv LH; Bai YN; Mao AY; Liao XZ; Liu GX; Ren JS; Sun XJ; Zhu XY; Zhou JY; Gong JY; Zhou Q; Zhu L; Liu YQ; Song BB; Du LB; Xing XJ; Lou PA; Sun XH; Qi X; Wu SL; Cao R; Lan L; Ren Y; Zhang K; He J; Zhang JG; Dai M;
    Chin J Cancer; 2017 Sep; 36(1):73. PubMed ID: 28882179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Economic evaluation on breast cancer screening in mainland China: a systematic review].
    Wang L; Shi JF; Huang HY; Zhu J; Li J; Fang Y; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Dec; 37(12):1662-1669. PubMed ID: 27998418
    [No Abstract]   [Full Text] [Related]  

  • 7. Expenditure and financial burden for the diagnosis and treatment of colorectal cancer in China: a hospital-based, multicenter, cross-sectional survey.
    Huang HY; Shi JF; Guo LW; Bai YN; Liao XZ; Liu GX; Mao AY; Ren JS; Sun XJ; Zhu XY; Wang L; Song BB; Du LB; Zhu L; Gong JY; Zhou Q; Liu YQ; Cao R; Mai L; Lan L; Sun XH; Ren Y; Zhou JY; Wang YZ; Qi X; Lou PA; Shi D; Li N; Zhang K; He J; Dai M
    Chin J Cancer; 2017 Apr; 36(1):41. PubMed ID: 28454595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A systematic review of the economic burden of influenza in China].
    Zhu AQ; Zheng YM; Qin Y; Liu SS; Cui JZ; Li ZL; Li S; Feng LZ; Li ZJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Oct; 53(10):1043-1048. PubMed ID: 31607053
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical expenditure for liver cancer in urban China: A 10-year multicenter retrospective survey (2002-2011).
    Qiu WQ; Shi JF; Guo LW; Mao AY; Huang HY; Hu GY; Dong P; Bai FZ; Yan XL; Liao XZ; Liu GX; Bai YN; Ren JS; Sun XJ; Zhu XY; Zhou JY; Gong JY; Zhu L; Mai L; Du LB; Zhou Q; Xing XJ; Song BB; Liu YQ; Lou PA; Sun XH; Wu SL; Cao R; Qi X; Lan L; Ren Y; Zhang K; He J; Qu C; Dai M
    J Cancer Res Ther; 2018 Jan; 14(1):163-170. PubMed ID: 29516981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cancer burden in the Jinchang cohort].
    Bai Y; Qu H; Pu H; Dai M; Cheng N; Li H; Chang S; Li J; Kang F; Hu X; Ren X; He J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Mar; 37(3):306-10. PubMed ID: 27005525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expenditure and Financial Burden for Stomach Cancer Diagnosis and Treatment in China: A Multicenter Study.
    Zhang K; Yin J; Huang H; Wang L; Guo L; Shi J; Dai M
    Front Public Health; 2020; 8():310. PubMed ID: 32850573
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimating the economic burden of colorectal cancer in China, 2019-2030: A population-level prevalence-based analysis.
    Wang H; Li YJ; Lei L; Liu CC; Chen WQ; Dai M; Wang X; Lew JB; Shi JF; Li N; He J
    Cancer Med; 2024 Jan; 13(1):e6787. PubMed ID: 38112048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on direct economic burden and influencing factors in patients with cervical cancer and precancerous lesions].
    Tao SY; Peng JR; Wang Y; Zhang GT; Chen ZY; Zhao F; Ma JQ; Yang X; Qiao YL; Zhao FH; Yang CX
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Dec; 52(12):1281-1286. PubMed ID: 30522231
    [No Abstract]   [Full Text] [Related]  

  • 14. No expenditure difference among patients with liver cancer at stage I
    Lei H; Lei L; Shi J; Wu Y; Liang L; Huang H; He M; Bai F; Cao M; Qiu H; Wang Y; Liu C; Du J; Wang H; Zhang Y; Cao M; Peng J; Li N; Qu C; Dai M; Chen W; He J
    Chin J Cancer Res; 2020 Aug; 32(4):516-529. PubMed ID: 32963464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical expenditures for colorectal cancer diagnosis and treatment: A 10-year high-level-hospital-based multicenter retrospective survey in China, 2002
    Shi J; Liu G; Wang H; Mao A; Liu C; Guo L; Huang H; Ren J; Liao X; Bai Y; Sun X; Zhu X; Wang J; Song B; Zhou J; Zhu L; Lei H; Liu Y; Liu Y; Du L; He Y; Zhang K; Li N; Chen W; Dai M; He J
    Chin J Cancer Res; 2019 Oct; 31(5):825-837. PubMed ID: 31814686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic burden of gastrointestinal cancer under the protection of the New Rural Cooperative Medical Scheme in a region of rural China with high incidence of oesophageal cancer: cross-sectional survey.
    Li X; Cai H; Wang C; Guo C; He Z; Ke Y
    Trop Med Int Health; 2016 Jul; 21(7):907-16. PubMed ID: 27125226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-level economic burden of lung cancer in China: Provisional prevalence-based estimations, 2017
    Liu C; Shi J; Wang H; Yan X; Wang L; Ren J; Parascandola M; Chen W; Dai M
    Chin J Cancer Res; 2021 Feb; 33(1):79-92. PubMed ID: 33707931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unbalanced Treatment Costs of Breast Cancer in China: Implications From the Direct Costs of Inpatient and Outpatient Care in Liaoning Province.
    Ma Z; Deng G; Meng Z; Ma Y; Wu H
    Int J Health Policy Manag; 2022 Sep; 11(9):1735-1743. PubMed ID: 34380200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical and non-medical expenditure for breast cancer diagnosis and treatment in China: a multicenter cross-sectional study.
    Liao XZ; Shi JF; Liu JS; Huang HY; Guo LW; Zhu XY; Xiao HF; Wang L; Bai YN; Liu GX; Mao AY; Ren JS; Sun XJ; Mai L; Liu YQ; Song BB; Gong JY; Zhou JY; Du LB; Zhou Q; Cao R; Zhu L; Ren Y; Lou PA; Lan L; Sun XH; Qi X; Wang YZ; Zhang K; He J; Dai M;
    Asia Pac J Clin Oncol; 2018 Jun; 14(3):167-178. PubMed ID: 28670694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the economic burden of diagnosis and treatment of tuberculosis patients in rural China.
    Pan HQ; Bele S; Feng Y; Qiu SS; Lü JQ; Tang SW; Shen HB; Wang JM; Zhu LM
    Int J Tuberc Lung Dis; 2013 Dec; 17(12):1575-80. PubMed ID: 24200271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.